Incidence of Hepatitis C Infection among Prisoners by Routine Laboratory Values during a 20-Year Period

• Published in: PloS one Vol. 9; no. 2; p. e90560
• Main Authors: Marco, Andrés, Gallego, Carlos, Caylà, Joan A.
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 28.02.2014; Public Library of Science (PLoS)
• Subjects: Adult; Analgesics, Opioid - therapeutic use; Analysis; Biology; Coinfection - epidemiology; Confidence intervals; Drug abuse; Follow-Up Studies; Health aspects; Health risk assessment; Hepacivirus - immunology; Hepacivirus - physiology; Hepatitis; Hepatitis C; Hepatitis C - diagnosis; Hepatitis C - epidemiology; Hepatitis C - virology; Hepatitis C Antibodies - blood; Hepatitis C Antibodies - immunology; Hepatitis C virus; HIV; HIV infections; HIV Infections - epidemiology; Human immunodeficiency virus; Humans; Incidence; Infection; Infections; Intravenous administration; Male; Mathematical analysis; Medical research; Medicine; Methadone; Methadone - therapeutic use; Middle Aged; Minority & ethnic groups; Multivariate Analysis; Observational studies; Population studies; Prisoners; Prisoners - statistics & numerical data; Prisons; Proportional Hazards Models; Regression analysis; Retrospective Studies; Seroconversion; Serology; Social and Behavioral Sciences; Spain - epidemiology; Statistical analysis; Substance Abuse, Intravenous - epidemiology; Substance Abuse, Intravenous - prevention & control; Time Factors; Viruses; Spain; United States > US; Europe
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0090560

To estimate the incidence of Hepatitis C virus (HCV) and the predictive factors through repeated routine laboratory analyses. An observational cohort study was carried out in Quatre Camins Prison, Barcelona. The study included subjects with an initial negative HCV result and routine laboratory analyses containing HCV serology from 1992 to 2011. The incidence of infection was calculated for the study population and for sub-groups by 100 person-years of follow-up (100 py). The predictive factors were determined through Kaplan-Meier curves and a Cox regression. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated. A total of 2,377 prisoners were included with a median follow-up time of 1,540.9 days per patient. Among the total population, 117 HCV seroconversions were detected (incidence of 1.17/100 py). The incidence was higher between 1992 and 1995 (2.57/100 py), among cases with HIV co-infection (8.34/100 py) and among intravenous drug users (IDU) without methadone treatment (MT) during follow-up (6.66/100 py). The incidence rate of HCV seroconversion among cases with a history of IDU and current MT was 1.35/100 py, which is close to that of the total study population. The following variables had a positive predictive value for HCV infection: IDU (p<0.001; HR = 7,30; CI: 4.83-11.04), Spanish ethnicity (p = 0.009; HR = 2,03; CI: 1.93-3.44) and HIV infection (p = 0.015; HR = 1.97; CI: 1.14-3.39). The incidence of HCV infection among prisoners was higher during the first part of the study and among IDU during the entire study period. Preventative programs should be directed toward this sub-group of the prison population.